Prevalence of breast carcinoma in situ in the United States

JAMA

Volumn 302, Issue 8, 2009, Pages 846-848

  Sprague, Brian L ^a   Trentham Dietz, Amy ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BREAST CARCINOMA; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HUMAN; INTRADUCTAL CARCINOMA; LETTER; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; UNITED STATES; ARTICLE; BREAST TUMOR; CANCER REGISTRY; LUNG CARCINOMA; SURVIVOR;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; FEMALE; HUMANS; PREVALENCE; SEER PROGRAM; SURVIVORS; UNITED STATES;

EID: 69249215463     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.1211     Document Type: Letter

References (6)

1. Ries LA, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975- 2005 [based on November 2007 SEER data submission, posted to the SEER Web site 2008]. http://seer.cancer.gov/csr/1975-2005/. Accessed July 24, 2009.
2. Rakovitch E, Franssen E, Kim J, et al. A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat. 2003;77(3):285-293. (Pubitemid 36197643)
3. Warnberg F, Yuen J, Holmberg L. Risk of subsequent invasive breast cancer after breast carcinoma in situ. Lancet. 2000;355(9205):724-725. (Pubitemid 30107633)
4. Surveillance Epidemiology and End Results (SEER) Stat Database [released April 2008, based on the November 2007 submission]. http://www.seer.cancer.gov. Accessed July 28, 2009.
5. Gail MH, Kessler L, Midthune D, Scoppa S. Two approaches for estimating disease prevalence from population-based registries of incidence and total mortality. Biometrics. 1999;55(4):1137-1144.
6. Capocaccia R, De Angelis R. Estimating the completeness of prevalence based on cancer registry data. Stat Med. 1997;16(4):425-440. (Pubitemid 27073011)